fbpx
CALL US: 210-949-0122
Studies for Seniors »

by: Clinical Trials of Texas, Inc.

Every 68 seconds, someone is diagnosed with Alzheimer’s disease.

Researchers are expecting the incidence of the disease to triple by the year 2050; only 40 years away. The reason?

Experts say that our population is living longer and have access to much better healthcare than ever before. The baby boom generation will be reaching 70 and older, an age that doctors say they see Alzheimer’s become more prevalent.

The problem now lies in the fact that there is no proven treatment to slow or prevent the occurrence of Alzheimer’s disease. Several clinical trials that are being conducted do show promise, but as of yet, no for sure treatment.

The more devastating news is that Alzheimer’s disease is a very slow progressing disease that only gets worse once onset occurs. Physicians say that those with the disease usually have it for an estimated three to nine years.

Clinical Trials of Texas and its physicians are working hard to conduct research and spread awareness of the very early stages of the disease.

Dr. Kate Glywasky, neuropsychologist at CTT is working closely with the Alzheimer’s Association in San Antonio. Dr. Glywasky will be speaking this coming Friday, May 15th, at the Whitley Center in San Antonio during the San Antonio Educational Summit on Alzheimer’s disease.

Don’t miss this educational event! If you can’t make it, check out CTT’s website for a recap. To learn more about participating in a research study for Alzheimer’s disease, visit SAresearch.com or call 210.949.0122.